Stablix Appoints Douglas Williams, Ph.D., to Board of DirectorsBy Publishing TeamJanuary 18, 2023 NEW YORK, Jan. 18, 2023 (GLOBE NEWSWIRE) — Stablix, Inc., a biopharmaceutical company pioneering targeted protein stabilization (TPS) as a…
